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Dengue fever is a tropical disease and caused by dengue virus (DENV), which is transmitted by mosquitoes and infects about 
400 million people annually. With the development of international trade and travel, China is facing a growing threat. Over 40 
thousands of people were infected during the 2014 DENV outbreak in Guangdong. Neither licensed vaccine nor therapeutic 
drug has been available. In this report, we isolated two clinical DENV strains. The full-length genome was sequenced and 
characterized. We also applied a flavonoid, CPI, into an anti-DENV assay. Replication of viral RNA and expression of viral 
protein was all strongly inhibited. These results indicated that CPI may serve as potential protective agents in the treatment of 
patients with chronic DENV infection. 
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Dengue fever is a mosquito-borne tropical disease caused 
by the dengue virus (DENV). DENV belongs to the Fla-
viviridae family. Usually, the virus is transmitted to humans 
by the bite of infected Aedes aegypti or Aedes albopictus 
mosquitoes (Higa, 2011). There are four DENV serotypes 
(DENV1–4) (Holmes and Twiddy, 2003; Vasilakis and 
Weaver, 2008). Infection with any one of the four serotypes 
can lead to dengue fever. Clinically, fever, rash, lethargy 
and joint pain are the most common presentations. A small 
proportion of severe cases could develop into dengue 
haemorrhagic fever or dengue shock syndrome, or even 
result in death. A fifth DENV serotype was detected in 2013 
(Normile, 2013). The DENV genome contains about 11,000 
nucleotide bases, which code for the three structural pro-
teins (C, prM and E) that form the viral particles and seven 
other non-structural proteins (NS1, NS2a, NS2b, NS3, 
NS4a, NS4b, NS5) that are only found in infected host cells 
and are involved in viral replication. 
About 400 million people worldwide are infected with 
DENV annually (Bhatt et al., 2013; Thomas and Endy, 
2011). In mainland China, from 1978 to 2008, a total of 
655,324 cases of dengue fever, including 610 deaths, were 
reported (Wu et al., 2010). From 2009 to 2014, 52,749 cases 
and six deaths were notified (Chen and Liu, 2015). Unfor-
tunately, neither commercially vaccine nor antiviral treat-
ment for DENV is available. Clinical infections are usually 
treated with supportive treatment, by using either oral or 
intravenous rehydration. An effective antiviral therapy 
against DENV infection is urgently needed. 
Flavonoids are a large group of naturally occurring phe-
nylchromones and are present in all vascular plants. Antivi-
ral activities of numerous flavonoids have been reported. 
Replication of a number of viruses can be inhibited by bai-
calein, a member of the flavone subgroup of flavonoids, 
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including herpes simplex viruses 1 and 2 (HSV-1 and 
HSV-2) and Japanese encephalitis virus (JEV) (Johari et al., 
2012; Lyu et al., 2005). In our previous study, we showed 
that 7-hydroxyflavone and 5,7-dihydroxyflavone substan-
tially inhibited replication of enterovirus 71 in infected cells 
(Wang et al., 2014a, 2014b). It has been reported that ex-
tract of scutellaria baicalensis, which is rich in baicalein, 
reduced all four types of DENV infectivity and replication 
in cells (Zandi et al., 2013). Quercetin also demonstrated 
anti-DENV2 inhibitory activities in vitro (Zandi et al., 
2011).  
In this study, we isolated a clinical DENV1 strain and a 
DENV2 strain from patients with dengue infection. The 
genome was sequenced and characterized, which provided 
useful information to understand the DENV epidemic in 
China. We also tested the antiviral activity of diisopropyl 
chrysin-7-yl phosphate (CPI). CPI exhibited potent antiviral 
activity against both DENV1 and DENV2. 
RESULTS 
Acute phase serum from the patients who were clinically 
diagnosed as severe dengue fever was detected with DENV 
primers. PCR positive samples were inoculated in VERO 
cells. Cells were propagated for several passages until clear 
cytopathic effect (CPE) was observed. Viral RNA was ex-
tracted from cell culture supernatant and checked with 
DENV type specific primers. A DENV1 isolate and a 
DENV2 isolate was determined and the full-length genome 
was sequenced. 
The newly isolated DENV1 was named as SZ/2015. The 
complete genome sequences were submitted to GenBank 
under the accession number KU094071. The entire genome is 
10,736 nt in length. Phylogenetic analysis of DENV1 based 
on E gene is shown in Figure 1. The newly isolated 
DENV1/SZ/2015 belonged to the genotype American/Asian, 
clustering closely with the Indonesia/2015 isolate and two 
Pakistan/2014 isolates. At meanwhile, other DENV1 strains 
isolated in the first ten years of this century from China and 
other Southeast Asian countries mainly located in the Asian 
genotype. The newly isolated DENV2/ SZ/2015 was also 
sequenced and the complete genome sequences were submit-
ted to GenBank under the accession number KU094070. The 
entire genome is 10,723 nt in length. Phylogenetic analysis
 
 
Figure 1  (color online) Phylogenetic analyses of DNEV-1 isolates based on the complete envelope gene using the Neighbor-Joining method. 
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based on E gene for DENV2 is shown in Figure 2. The 
newly isolated DENV2/SZ/2015 belonged to the genotype 
Asian II, clustering closely with two former China isolates 
in 1987 and 1989. The E protein of these strains share 99% 
amino acid homology. This finding shows the newly isolat-
ed DENV2 strain has been stable in China for many years. 
To study the antiviral activity of CPI on DENV, VERO 
cells were infected at 1 TCID50/cell (50% tissue culture infec-
tive dose per cell). At the time of infection, a final concentra-
tion of 20 μmol L1 CPI was added to the culture medium. 
Control cells were exposed to 1% dissolved in dimethyl sul-
foxide (DMSO), which was used to dissolve the drug. Mor-
phological changes of infected cells were examined by 
phase-contrast microscopy at 72 hour post infection (hpi). 
Microscopic examination revealed that the CPE of both 
DENV1 and DENV2 on the VERO cells was noticeably in-
hibited by CPI (Figure 3).  
Viral genome copies in cells were determined for each  
group by quantitative real-time PCR. The copy number of 
GAPDH was used as an internal control. As shown in Figure 
4A, in DENV1 infected cells, viral genome copies in cells 
treated with 20 μmol L1 CPI fell substantially to 21% com-
pared to the control group. Replication of DENV2 also  
decreased to 17% of the control group when 20 μmol L1 CPI 
was added (Figure 4B). At meanwhile, synthesis of viral pro-
teins was detected by Western blot. And expression of cellular 
GAPDH was utilized as control. The results are shown in Fig-
ure 4C and D. Synthesis of viral protein was inhibited by CPI 
in both DENV1 and DENV2 infected cells, while expression 
of internal cellular GAPDH was not obviously suppressed. The 
concentration necessary to reduce the number of plaques by 
50% (50% inhibitory concentration, IC50) was determined as 
previously (Wang et al., 2014b). The IC50 of CPI against 
DENV1 and DENV2 was 18.6 and 15.1 μmol L1, respectively. 
 
 
Figure 2  (color online) Phylogenetic analyses of DNEV-2 isolates based on the complete envelope gene using the Neighbor-Joining method. 
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Figure 3  Effects of CPI on DENV1 and DENV2 infection. A, Mock 
infected VERO cells. B and D, DENV-1 and DENV-2 induced CPE in 
VERO cells. C and E, Virus-induced CPE were reduced by the drug treat-
ment. 
 
Figure 4  CPI inhibits both DENV1 and DENV2 replication in VERO 
cells. A and B, CPI inhibited the accumulation of viral RNA (P<0.05). The 
experiment was performed in triplicate; bars represent means±SD. C and D, 
Synthesis of viral protein in VERO cells was reduced by the addition of 
CPI.  
DISCUSSION 
In 2014, a series of dengue fever outbreaks occurred in 
Guangdong, China. 423 cases were reported on 22 August, 
however, the number had reached 42,358 by 31 October 
(Jin et al., 2015). The exact cause of this outbreak is still not 
clear. However, as the exchange is getting more and more 
frequent for travelers between China and countries in 
Southeast Asia and Africa, where mosquito-borne infectious 
diseases are rampant, the prevention or treatment of dengue 
fever is of great importance. In this study, we characterized 
two DNEV strains and examined the anti-DENV activity of 
CPI, a flavonoid from the flavone subgroup. We found that 
CPI was highly effective against both DENV1 and DENV2 
replication in cell cultures without obvious cytotoxicity. 
Together with other viruses, DENV infection usually  
induces generation of neutralizing antibodies, which protect 
the individuals from viral infection and even provide 
life-long protection against the homologous serotype  
(Imrie et al., 2007). Unfortunately, in a secondary infection 
by a different DENV serotype, the antibody from the pre-
vious infection could cross-react with the virus to form a 
non- neutralizing complex and result in enhancement of 
viral infection through a mechanism known as anti-
body-depen- dent enhancement (Halstead, 2003). Thus 
co-circulation of multiple DENV serotypes could finally 
increase the risk of secondary infection and the percentage 
of severe dengue cases. In mainland China, DENV1 had 
been thought to be predominant and responsible for the  
epidemics of dengue fever in southern China for decades 
(Wu et al., 2011). However, the other three types of DENV 
had also been frequently detected (Jiang et al., 2012;  
Zhao et al., 2012a, 2012b, 2014). In the present study, we 
characterized a DENV2 strain from Shenzhen, Guangdong. 
Phylogenetic analyses revealed that DENV2/SZ/2015 iso-
late was closely related to former China isolates. This find-
ing was consistent with previous report that DENV2 strains 
circulating in Guangdong have been stable since their in-
troduction (Zhao et al., 2014), indicating that dengue fever 
cannot be simply treated as an imported epidemic disease 
anymore. A DENV1 strain was also determined. In contrast 
to the DENV2 strain, the DENV1/SZ/2015 isolate was not 
very similar to former China isolates, but genetically close 
to the Southeast Asian isolates. This result suggested that 
the DENV1 isolate might be transmitted into China by the 
mosquitoes or travelers in the recent years, reminding us the 
risk for new DENV1 outbreak. Besides local dengue out-
break, there is still threaten from outside, especially from 
tropical and subtropical area. To conclude, our data further 
confirm that multiple serotypes of DNEV are coexisting in 
mainland China. Genetic diversities and various origins 
make the DENV threaten much more serious and compli-
cated.  
Plenty of works have been done to explore clinical  
therapy against DENV infection. Several neutralizing anti-
bodies have been characterized and showed potent neutral-
izing activity against DENV (Dejnirattisai et al., 2015; 
Fibriansah et al., 2015; Rouvinski et al., 2015; Smith et al., 
2013). DENV subunit vaccines are being developed, too 
(Coller et al., 2011). However, none of these are currently 
clinically available. Plants, including Chinese herbal for-
mulations, have been used to treat human diseases for cen-
turies. Additionally, antiviral activities have also been iden-
tified in several hundred natural compounds worldwide. For 
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example, lots of flavonoids possess antiviral activity, which 
are a large group of naturally occurring phenylchromones 
and can be found in fruits, vegetables, tea, soy foods, and 
herbs. Chrysin is a member from the flavone subgroup of 
flavonoid and has shown antiviral activity in our previous 
assay against enterovirus 71 (Wang et al., 2014b). As 
phosphorylated flavonoids usually demonstrated relatively 
stronger binding affinities and enhanced activity compared 
with non-phosphorylated forms (Chen et al., 2004, 2007). In 
the present study, we tested anti-DENV activity for CPI, the 
phosphate ester for chrysin. As expected, CPI was highly 
effective against infectious both DENV1 and DENV2 rep-
lication in cell cultures. CPI protected infected VERO cells 
from DENV induced CPE. Both viral genome replication 
and viral protein expression was substantially inhibited by 
the flavonoid. At meanwhile, no obvious cytotoxicity was 
observed, because VERO cells grew well and expression for 
cellular GAPDH was not affected in the control group. This 
finding of anti-DENV activity of natural compound was 
encouraging, because there are still a great of population 
still relies on traditional medicine for primary health care. 
Nevertheless, the inhibitory concentration for CPI at mi-
cromolar range was relatively high, we will try other modi-
fications of the flavones by organic synthesis to get more 
potent inhibitors. 
In conclusion, we characterized two clinical DENV iso-
lates and provided meaningful information to understand 
the DENV epidemic in China. We also demonstrated that 
CPI exerted a strong inhibitory effect on DENV replication. 
This result is particularly important because no effective 
antiviral drug is currently available for the prevention, 
treatment, and control of DENV infection. 
MATERIALS AND METHODS 
Cell culture and drug treatment 
African green monkey kidney cells (Vero; ATCC, USA) 
were propagated and maintained in Dulbecco’s Modified 
Eagle Medium (HyClone, Australia) supplemented with 
10% fetal bovine serum (Invitrogen, USA) plus 100 U mL1 
penicillin and 100 μg mL1 streptomycin at 37ºC with 5% 
CO2. Cell numbers and proliferation were determined by 
direct cell number counting using CountStar (Inno-Alliance 
Biotech, Beijing) after staining with trypan blue. CPI was 
synthesized from chrysin (5,7-dihydroxyflavone, C15H10O4, 
Mr: 254.24) by using a simplified Atheron-Todd reaction as 
described previously (Wang et al., 2014b). For cell experi-
ments, CPI was dissolved in dimethyl sulfoxide (DMSO) 
and then diluted in culture medium. To avoid toxicity or 
interference of the solvent, the maximum concentration of 
DMSO in the cell test medium was less than 0.1%. 
Virus isolation and identification 
Eight patients with the clinical symptoms of fever, chill, 
severe myalgia and confusion were diagnosed with dengue 
virus infection by Shenzhen Third People’s Hospital. Acute 
phase serum from the patients was collected and inoculated 
in VERO cells. Three samples induced complete cytopathic 
effects (CPE), from which culture supernatant was collect-
ed. Viral RNA was extracted from 140 μL cell culture su-
pernatant by using viral RNA mini kit (Qiagen, Germany), 
and reverse transcribed using the Superscript First-Strand 
Synthesis System (Invitrogen, USA) in a 20 μL reaction 
mixture with 1.2 μg total RNA and 50 ng random hexamers 
according to the manufacturer’s instructions. cDNA sam- 
Table 1  Primers utilized in genome amplification for DENV1 and DENV2 
















TCAGAGCACCATACCAGAGAC    GACGACACCGTTGCCATA 
GAAAGAATCCAAGAGCCGTCC CTTCAGGCGTGTTGATGTTA 
AGCACAAAGAAGAGGGAGAGT CATCCGATAGCGAGAAGG 
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ples were then subjected to PCR detection by using primers: 
DENV-F (5′-GTGCACACATTGACAGAACA-3′) and 
DENV-R (5′-CTTTCTATCCAATAACCCAT-3′), follow-
ing the guideline of Chinese Center for Disease Control and 
Prevention. After sequencing, positive samples were stored 
at 80°C until use. 
Complete genome sequencing 
Primers were designed on the basis of available GenBank 
genomic sequences of the DENV1 (KM204119) and 
DENV2 (AF204177), as shown in Table 1. Viral RNA was 
extracted and reverse transcribed by using random hex-
amers primers. Overlapping fragments covering each viral 
genome were then amplified. The PCR products were se-
quenced and assembled manually. 
Sequence alignment and phylogenetic analysis 
The full-length genome sequences of DENV1/China/ 
SZ/2015 and DENV2/China/SZ/2015 were aligned with 42 
and 41 complete sequences using ClustalW, respectively 
(http://www.clustal.org/). All sequences were deposited in 
GenBank (accession numbers as shown in figure). Phylo-
genetic trees for DENV1 and DENV2 based on the com-
plete envelope gene regions were constructed with Molecu-
lar Evolutionary Genetics Analysis (MEGA) version 5.0 
(Tamura et al., 2011). The evolutionary history was inferred 
using the Neighbor-Joining method (Saitou and Nei, 1987). 
The optimal tree with the sum of branch length=1.79014943 
is shown. The percentage of replicate trees in which the 
associated taxa clustered together in the bootstrap test 
(1,000 replicates) are shown next to the branches 
(Sanderson and Wojciechowski, 2000). The tree is drawn to 
scale, with branch lengths in the same units as those of the 
evolutionary distances used to infer the phylogenetic tree. 
The evolutionary distances were computed using the 
Tamura-Nei method (Tamura and Nei, 1993) and are in the 
units of the number of base substitutions per site. The rate 
variation among sites was modeled with a gamma distribu-
tion (shape parameter=1). The analysis involved 41 and 42 
nucleotide sequences respectively.  
Viral infection 
DENV-1 and DENV-2 viruses were propagated in VERO 
cells. When complete CPE was observed, culture superna-
tant was harvested to yield viruses at 105~106 TCID50 mL
1 
(50% tissue culture infectious doses) determined by using 
the Reed-Muench method (Reed and Muench, 1938). Ap-
proximately 105 cells were seeded into 24-well plate 12 h 
before infection. When reached 90% confluences, cells 
were infected with DENV-1 or DENV-2 viruses at 1 
TCID50 cell
1. CPI was added to cell cultures at the time of 
infection. Western blotting and quantitative real-time PCR 
were performed 24 hours post-infection (hpi) as described 
below. Representative results are shown.  
Quantitative real-time PCR 
Relative quantitative real-time PCR was conducted on an 
ABI Prism 7000 Real-time PCR System (Applied Biosys-
tems, USA) by using a Power SYBR Green PCR Master Kit 
(Applied Biosystems). Reactions were 2 μL cDNA, 1 μL of 
each primer and 25 μL Power SYBR Green PCR Master 
Mix in 50 μL volumes. Efficiency-corrected relative quan-
titation was used with GAPDH as an internal control (Pfaffl, 
2001).  
Western blot analysis 
Cells were pelleted by centrifugation and lysed in buffer 
containing 100 mmol L1 NaCl, 20 mmol L1 Tris (pH 8.0), 
0.5% NP-40, 0.25% sodium deoxycholate, and 1 mmol L1 
ethylene diamine tetraacetic acid (EDTA) with protease 
inhibitor cocktail (Roche, USA). Supernatant was collected 
and aliquots of cell lysate were electrophoresed on 10% 
sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) gels and transferred to nylon polyvinylidene 
difluoride membranes (PVDF, Hybond P, Piscataway, 
USA). The membranes were blocked with 5% bovine serum 
albumin (BSA), and proteins on the membrane were probed 
with primary antibodies at 4°C overnight followed by incu-
bation with corresponding IRD Fluor 680-labeled IgG sec-
ondary antibody (Li-Cor Inc., USA) for 1 h at room temper-
ature. After washing, the membranes were scanned with the 
Odyssey infrared imaging system (Li-Cor Inc., USA) at a 
wavelength of 700 nm, and the molecular sizes of the de-
veloped proteins were determined by a comparison with 
prestained protein markers (Fermentas, USA). The DENV1 
and DENV2 were detected by anti-DENV monoclonal an-
tibody (Abcam, USA). To control for protein loading, levels 
of the housekeeping protein GAPDH were assessed using 
mouse anti-GAPDH (Beyotime, Suzhou). 
Statistical analysis 
At least three independent experiments were carried out for 
each variable. Statistical significance was assessed with 
SSPS version 10.0. Differences were considered statistically 
significant at a threshold of P<0.05. All results are present-
ed as mean±SD. 
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